(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide(CAS: 658084-23-2)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide (3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide](https://cnstatic.chemtradehub.com/structs/658/658084-23-2-1d6b.webp)
CAS号
相关产品
其他供应商提供的 (3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide
基本信息
分子式
C28H30ClN5O4S
分子量
568.1 g/mol
化学标识符
SMILES
CN1CCN(CC1)C(=O)c1c(C)[nH]c(c1C)C=C1C(=O)Nc2c1cc(cc2)S(=O)(=O)N(c1cccc(c1)Cl)C
InChIKey
FPYJSJDOHRDAMT-KQWNVCNZSA-N
数据库引用
MDL号
MFCD08276928
常见问题
SU11274 抑制剂为无色晶体,熔点约为180°C。分子量约为533.9 g/mol。该化合物在有机溶剂中溶解度良好,如DMSO、DMF和THF。在水中的溶解度较低。该化合物具有良好的反应活性,能够参与多种化学反应,如酰基化、亲核取代等。
SU11274 抑制剂通常通过多步合成路线制备。首先,使用3-氯苯甲醛与3-氰基-1H-吡咯-2-酮进行缩合反应,然后对其进行酰化修饰,生成中间体。接下来,使用4-甲基哌啶酮对该中间体进行酰胺化反应,得到目标化合物。该过程需要严格控制反应条件,以确保高选择性和产率。
SU11274 抑制剂主要用于医药领域,作为一种抗癌药物,用于治疗某些类型的癌症。此外,该化合物还具有潜在的抗炎和免疫调节作用,因此也可能应用于其他生物医学研究和开发中。
处理SU11274 抑制剂时应佩戴适当的个人防护装备,如实验室外套、手套和护目镜。在通风橱中进行操作,避免吸入挥发性物质或遇到皮肤接触。应配备紧急洗眼器和淋浴设施。遇到泄露时,应立即清理并妥善处理,避免污染环境。查阅安全数据表(SDS)获取更多信息。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
邮箱
market@eastbangpharma.com

![(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid](https://cnstatic.chemtradehub.com/structs/229/229614-55-5-c407.webp)
![5-(Imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile](https://cnstatic.chemtradehub.com/structs/106/106730-54-5-9092.webp)
![8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione hydrochloride (1:1)](https://cnstatic.chemtradehub.com/structs/333/33386-08-2-4999.webp)
![Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-5,6-dioxo-1,2,5,6-tetrahydropyrimidin-2-ide](https://cnstatic.chemtradehub.com/structs/871/871038-72-1-53e3.webp)


![N'-{5-[Acetyl(hydroxy)amino]pentyl}-N-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-N-hydroxysuccinamide methanesulfonate (1:2)](https://cnstatic.chemtradehub.com/structs/138/138-14-7-b70f.webp)
![6,7-Dimethoxy-2-[4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl]quinazolin-4-amine hydrochloride_x000D_](https://cnstatic.chemtradehub.com/structs/635/63590-64-7-68da.webp)
![1-{3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide](https://cnstatic.chemtradehub.com/structs/103/103628-46-2-955f.webp)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide — 上海创赛科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecce82b2de6e8e95a5e02/67cecce82b2de6e8e95a5e02-logo.webp)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide — 上海迈瑞尔生化科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ced3b52b2de6e8e95a6e52/67ced3b52b2de6e8e95a6e52-logo.webp)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide — 天门恒昌化工有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecc092b2de6e8e95a5bbe/67cecc092b2de6e8e95a5bbe-logo.webp)
![(3Z)-N-(3-Chlorophenyl)-3-({3,5-dimethyl-4-[(4-methyl-1-piperazinyl)carbonyl]-1H-pyrrol-2-yl}methylene)-N-methyl-2-oxo-5-indolinesulfonamide — 上海源叶生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce9f132b2de6e8e95a48fe/67ce9f132b2de6e8e95a48fe-logo.webp)